Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis from Colorectal Cancer: A Multi-Institutional Study

Journal of Clinical Oncology

Volumn 22, Issue 16, 2004, Pages 3284-3292

  Glehen, O ^b   Kwiatkowski, F ^b   Sugarbaker, P H ^b   Elias, D ^b   Levine, E A ^b   De Simone, M ^b   Barone, R ^b   Yonemura, Y ^b   Cavaliere, F ^b   Quenet, F ^b   Gutman, M ^b   Tentes, A A K ^b   Lorimier, G ^b   Bernard, J L ^b   Bereder, J M ^b   Porcheron, J ^b   Gomez Portilla, A ^b   Shen, P ^b   Deraco, M ^b   Rat, P ^b   Gilly, Francois N ^a   more..

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADOLESCENT; AGED; CARCINOMA; COLORECTAL TUMOR; FEMALE; INFUSION; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PERITONEUM TUMOR; RETROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4344619216     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.10.012     Document Type: Article

References (44)

1. Dawson LE, Russell AH, Tong D, et al: Adenocarcinoma of the sigmoid colon: Sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 22:95-99, 1983
2. Chu DZ, Lang NP, Thompson C, et al: Peritoneal carcinomatosis in nongynecologic malignancy: A prospective study of prognostic factors. Cancer 63:364-367, 1989
3. Knorr C, Reingruber B, Meyer T, et al: Peritoneal carcinomatosis of colorectal cancer: Incidence, prognosis, and treatment modalities. Int J Colorectal Dis 19:181-187, 2004
4. Improved survival with preoperative radiotherapy in resectable rectal cancer: Swedish Rectal Cancer Trial. N Engl J Med 336:980-987, 1997
5. Brodsky JT, Cohen AM: Peritoneal seeding following potentially curative resection of co-Ionic carcinoma: Implications for adjuvant therapy. Dis Colon Rectum 34:723-727, 1991
6. Sadeghi B, Arvieux C, Glehen O, et al: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358-363, 2000
7. Jayne DG, Fook S, Loi C, et al: Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545-1550, 2002
8. Isacoff WH, Borud K: Chemotherapy for the treatment of patients with metastatic colorectal cancer: An overview. World J Surg 21:748-762, 1997
9. Machover D: A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer 80: 1179-1187, 1997
10. Midgley R, Kerr D: Colorectal cancer. Lancet 353:391-399, 1999
11. Douillard JY, Cunningham D, Roth AD, et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 355:1041-1047, 2000
12. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000
13. Sugarbaker PH: Peritonectomy procedures. Ann Surg 221:29-42, 1995
14. Glehen O, Mithieux F, Osinsky D, et al: Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 21:799-806, 2003
15. Sugarbaker PH: Carcinomatosis: Is cure an option? J Clin Oncol 21:762-764, 2003
16. Elias D, Blot F, El Otmany A, et al: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71-76, 2001
17. Glehen O, Gilly FN, Sugarbaker PH: New perspectives in the management of colorectal cancer: What about peritoneal carcinomatosis? Scand J Surg 92:178-179, 2003
18. Shen P, Levine EA, Hall J, et al: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138:26-33, 2003
19. Pestieau SR, Sugarbaker PH: Treatment of primary colon cancer with peritoneal carcinomatosis: Comparison of concomitant vs. delayed management. Dis Colon Rectum 43:1341-1346, 2000
20. Witkamp AJ, de Bree E, Kaag MM, et al: Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979-984, 2001
21. Verwaal V, Ruth S, Bree E, et al: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-3743, 2003
22. Gilly FN, Beaujard A, Glehen O, et al: Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: Phase I-II study. Anti-cancer Res 19:2317-2321, 1999
23. Porcheron J, Talabard JN, Breton C, et al: Intraperitoneal chemohyperthermia for peritoneal carcinomatosis: Original modeling, clinical tolerance and results study about 30 patients. Hepatogastroenterology 47:1411-1418, 2000
24. Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359-374, 1996
25. Kaplan EL, Meier P: Non parametric estimation for observations. J Am Stat Assoc 53:457-481, 1958
26. Mantel N, Haenszel W: Statistical aspect of the analysis of data from restrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959
27. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-202, 1972
28. Kwiatkowski F, Girard M, Hacene K, et al: Sem: A suitable statistical software adaptated for research in oncology. Bull Cancer 87:715-721, 2000
29. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124-132, 1995
30. Fujimura T, Yonemura Y, Fujita H, et al: Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intraabdominal malignancies. Int Surg 84:60-66, 1999
31. Beaujard AC, Glehen O, Caillot JL, et al: Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88:2512-2519, 2000
32. Cavaliere F, Perri P, Di Filippo F, et al: Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 74:41-44, 2000
33. Culliford ATt, Brooks AD, Sharma S, et al: Surgical debulking and Intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 8:787-795, 2001
34. Pilati P, Mocellin S, Rossi CR, et al: Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 10:508-513, 2003
35. Elias D. Pocard M: Treatment and prevention of peritoneal carcinomatosis from colorectal cancer. Surg Oncol Clin N Am 12:543-559, 2003
36. Cavaliere F, Perri P, Rossi CR, et al: Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: Experience of the Italian Society of Locoregional Integrated Therapy in Oncology. Tumori 89:21-23, 2003
37. Stephens AD, Alderman R, Chang D, et al: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790-796, 1999
38. Glehen O, Osinski D, Cotte E, et al: Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863-869, 2003
39. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection - Registry of Hepatic Metastases. Surgery 103:278-288, 1988
40. Elias DM, Ouellet JF: Intraperitoneal chemohyperthermia: Rationale, technique, indications, and results. Surg Oncol Clin N Am 10:915-933, 2001
41. de Bree E, van Ruth S, Baas P, et al: Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 121:480-487, 2002
42. Ceelen WP, Hesse U, de Hemptinne B, et al: Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intraabdominal cancer. Br J Surg 87:1006-1015, 2000
43. Crile G: The effect of heat and radiation on cancers implanted in the feet of mice. Cancer Res 23:372-380, 1963
44. Teicher BA, Kowal CD, Kennedy KA, et al: Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 41:1096-1099, 1981